Loading…
Personalis, Inc. is projected to rise to $15.42 by 2027, a +22% move from its current price of $12.66. PSNL is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $12.16 | $12.67 | $13.21 | +0.10% |
| Aug 3 | $11.97 | $12.69 | $13.45 | +0.21% |
| Aug 4 | $11.82 | $12.70 | $13.64 | +0.31% |
| Aug 5 | $11.70 | $12.71 | $13.81 | +0.42% |
| Aug 6 | $11.60 | $12.73 | $13.96 | +0.52% |
| Aug 7 | $11.51 | $12.74 | $14.10 | +0.63% |
| Aug 8 | $11.43 | $12.75 | $14.23 | +0.73% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $11.43 | $12.75 | $14.23 | +0.73% |
| Week 2 | $11.00 | $12.85 | $15.00 | +1.46% |
| Week 3 | $10.70 | $12.94 | $15.64 | +2.20% |
| Week 4 | $10.47 | $13.03 | $16.22 | +2.95% |
| Week 5 | $10.28 | $13.13 | $16.77 | +3.70% |
| Week 6 | $10.11 | $13.22 | $17.29 | +4.46% |
| Week 7 | $9.97 | $13.32 | $17.79 | +5.22% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally. The company offers NeXT Personal, a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD), therapy response and recurrence monitoring in solid tumor cancers; ImmunoID NeXT, a tissue-based service that combines whole exome and whole transcriptome sequencing data with advanced analytics to provide a multi-dimensional view of the tumor and the tumor microenvironment from a single sample.
It also provides NeXT Personal Dx, a tumor-informed liquid biopsy test for the detection of MRD; and NeXT Dx, a tumor profiling test that is used to help select therapy for a cancer patient and identify potential clinical trials for a patient. In addition, the company performs whole exome sequencing of cancer tissue and matched blood samples for diagnostic companies as an input to their products; and whole genome sequencing on human samples for research projects, such as population sequencing initiatives.
PSNL is the stock ticker for Personalis, Inc., a healthcare company focused on cancer genomic testing and sequencing services. The company’s current price is $12.22 with a market cap of $1.3B and a rank of 2306. The near-term technical picture shows a bullish trajectory with a 30-day technical frame supporting upside potential.
A major floor 60.2% below — a decisive break under it would weaken the trend.
The nearest floor, 20.5% below — buyers have tended to step in here.
The nearest ceiling, 24.7% above — a clean break opens room to run.
A major ceiling 46.7% above — clearing it would confirm fresh momentum.
Key PSNL support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PSNL market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $12.11 | Buy | $12.32 | Buy |
| MA 10 | $12.38 | Buy | $12.60 | Buy |
| MA 20 | $13.59 | Sell | $12.80 | Sell |
| MA 50 | $11.86 | Buy | $11.74 | Buy |
| MA 100 | $9.18 | Buy | $10.37 | Buy |
| MA 200 | $9.05 | Buy | $9.06 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.11 | Neutral |
| Stoch RSI (14) | 24.53 | Neutral |
| CCI (20) | -51.13 | Neutral |
| Williams %R (14) | -77.09 | Info |
| MACD (12,26,9) | -0.36 | Sell |
| ROC (12) | -19.82 | Sell |
| Bollinger %B (20,2) | 0.33 | Neutral |
| Stochastic %K (14) | 22.91 | Neutral |
| TRIX (15) | 0.49 | Buy |
| Awesome (5,34) | -0.63 | Sell |
| Ultimate (7,14,28) | 48.51 | Neutral |
| Momentum (10) | -2.73 | Sell |
| Aroon Osc (25) | -40.00 | Sell |
| Hull MA (9) | 12.08 | Buy |
| ADX (14) | 23.18 | Buy |
| ATR (14) | 0.46 | Info |
The 30-day picture shows bullish sentiment with RSI14 at 40. The SMA50 is $11.20 and the SMA200 is $8.93, indicating some positive momentum relative to longer-term averages. Support is at $9.42 and resistance at $15.79, offering a defined range for near-term moves.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.04 | $12.66 | $18.12 | 0% | Neutral | |
| $11.72 | $15.42 | $21.76 | +22% | Bullish | |
| $14.58 | $20.07 | $29.87 | +59% | Bullish | |
| $17.50 | $25.01 | $38.77 | +98% | Bullish | |
| $24.11 | $35.66 | $57.17 | +182% | Bullish | |
| $28.26 | $43.12 | $71.17 | +241% | Bullish | |
| $27.11 | $42.60 | $72.17 | +236% | Bullish | |
| $31.95 | $51.63 | $89.54 | +308% | Bullish | |
| $33.41 | $55.47 | $98.27 | +338% | Bullish | |
| $31.91 | $54.37 | $98.25 | +329% | Bullish | |
| $55.62 | $107.01 | $209.80 | +745% | Bullish | |
| $128.12 | $284.71 | $626.86 | +21.5x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $5.04 | $12.66 | $15.32 | +0.00% |
| September 2026 | $10.71 | $12.87 | $16.03 | +1.65% |
| October 2026 | $11.47 | $13.92 | $17.61 | +8.15% |
| November 2026 | $11.65 | $14.26 | $18.28 | +2.46% |
| December 2026 | $11.33 | $13.98 | $18.12 | -1.99% |
Click any year to see its month-by-month PSNL forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, PSNL is projected to trade between $5.04 and $18.12, averaging $12.66 — a potential gain of 0% from today's $12.66. Price action looks broadly range-bound.
Personalis, Inc.'s 2027 outlook centres on $15.42, within a $11.72 to $21.76 range. That is up +22% on the projected 2026 average. That marks a +22% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, PSNL could reach as high as $29.87, with a base case around $20.07 and support toward $14.58 — roughly +59% from $12.66. Momentum favours further upside here.
Expect PSNL to range from $17.50 to $38.77 through 2029. The $25.01 average target implies a +98% move from current prices. That is up +25% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The PSNL price prediction for 2030 points to an average of $35.66 (low $24.11, high $57.17) — a potential gain of +182% on today's $12.66. Momentum favours further upside here.
In 2031, PSNL is projected to trade between $28.26 and $71.17, averaging $43.12 — a potential gain of +241% from today's $12.66. That is up +21% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Personalis, Inc.'s 2032 outlook centres on $42.60, within a $27.11 to $72.17 range. That is -1% versus the projected 2031 average. That marks a +236% change versus current levels. Momentum favours further upside here.
By 2033, PSNL could reach as high as $89.54, with a base case around $51.63 and support toward $31.95 — roughly +308% from $12.66. Buyers look set to stay in control over this stretch.
Expect PSNL to range from $33.41 to $98.27 through 2034. The $55.47 average target implies a +338% move from current prices. That is up +7% on the projected 2033 average. Momentum favours further upside here.
The PSNL price prediction for 2035 points to an average of $54.37 (low $31.91, high $98.25) — a potential gain of +329% on today's $12.66. Buyers look set to stay in control over this stretch.
In 2040, PSNL is projected to trade between $55.62 and $209.80, averaging $107.01 — a potential gain of +745% from today's $12.66. That is up +97% on the projected 2035 average. Momentum favours further upside here.
Personalis, Inc.'s 2050 outlook centres on $284.71, within a $128.12 to $626.86 range. That is up +166% on the projected 2040 average. That marks a +21.5x change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in PSNL today (≈ 78.988942 PSNL) could be worth
$22,488.68
+$21,488.68 (+2149%) by 2050 · US Dollar
Based on the average projected PSNL price of $284.71 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PSNLwould be worth at today's price.
$1,000 invested in PSNL on Jul 31, 2025 (≈ 182.481751 PSNL) would be worth
$2,310.22
+$1,310.22 (+131.0%) today · 2.31× · US Dollar
Based on a PSNL entry price of $5.48 vs. today's $12.66.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $11.78 | $1,074.7 | +7.5% |
| 1 month ago | $13.79 | $918.06 | -8.2% |
| 3 months ago | $5.78 | $2,190.31 | +119.0% |
| 6 months ago | $9.35 | $1,354.01 | +35.4% |
| 1 year ago | $5.48 | $2,310.22 | +131.0% |
| All time (5.0y) ago | $20.81 | $608.36 | -39.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PSNL forecast.
Our base-case forecast reaches $25.00 around 2029.
Implied market cap at $25.00: $2.67B
The multi-year forecast paints a strong long-run ascent. For 2026 the min is $5.04, the avg is $12.22, the max is $17.83 with ROI 0 and sentiment NEUTRAL. The path continues with 2027 avg $14.81 (ROI 21.2, sentiment BULLISH) and 2028 avg $19.20 (ROI 57.1).
By 2029 the avg is $24.59 (ROI 101.2), and by 2030 the avg rises to $35.74 (ROI 192.5). The forecast extends through 2031 with avg $42.46 (ROI 247.4), 2032 avg $41.57 (ROI 240.2), 2033 avg $51.18 (ROI 318.9), 2034 avg $53.18 (ROI 335.2), and 2035 avg $51.46 (ROI 321.1). Looking further out, 2040 shows an avg of $102.67 (ROI 740.2) and 2050 shows an avg of $285.69 (ROI 2237.9).
These figures imply substantial long-term upside, tempered by near-term uncertainty. The forecasts are estimates and not guarantees, and actual results can differ due to market and company-specific factors.
Tap a question to reveal the answer.
The 2026 forecast lists min $5.04, avg $12.22, max $17.83 with ROI 0 and sentiment NEUTRAL.
The 2030 max is $59.59, just under $60. The 2031 max is $73.09, which would exceed $60.
RSI14 is 40 with bullish sentiment. The SMA50 is $11.20 and the SMA200 is $8.93. Support is at $9.42 and resistance at $15.79; the 30-day range runs from $8.95 to $16.68.
PSNL trades at $12.22 with a market cap of $1.3B and a rank of 2306.
By 2030 the avg is $35.74 with ROI 192.5; by 2040 the avg is $102.67 with ROI 740.2; by 2050 the avg is $285.69 with ROI 2237.9. These are estimates and involve uncertainty.
Personalis, Inc. Community Discussion
0Share your Personalis, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.